HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
26 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
MYO1C
myosin IC
Chromosome 17 · 17p13.3
NCBI Gene: 4641Ensembl: ENSG00000197879.17HGNC: HGNC:7597UniProt: F5H6E2
243PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
RESEARCH IMPACT
Trending
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
membranenuclear bodysmall GTPase bindingregulation of bicellular tight junction assemblyneurodegenerative diseaseautosomal dominant nonsyndromic hearing losscutaneous Leishmaniasisatrial fibrillation
✦AI Summary

MYO1C (myosin IC) is an unconventional motor protein with diverse cellular functions spanning cytoplasmic motility and nuclear transcriptional regulation. The gene produces three alternatively spliced isoforms with distinct N-terminal regions that exhibit different enzymatic behaviors and nuclear-cytoplasmic partitioning 1. In the cytoplasm, MYO1C functions as an actin-based motor protein essential for cell migration, with its stability regulated by RNF41-mediated polyubiquitination that promotes actin remodeling 2. MYO1C plays critical roles in wound healing through keratinocyte proliferation and migration via interaction with Dock5 3. In nuclear functions, MYO1C cooperates with chr17 remodeling complexes like KAT6B for transcriptional regulation 4. The protein is implicated in several pathological conditions: it serves as a potential urinary biomarker for diabetic nephropathy, where it mediates podocyte injury through p38 MAPK signaling 5; promotes prostate cancer metastasis when stabilized by RNF41 2; and contributes to proper rhodopsin localization in photoreceptors, with dysfunction leading to retinal degeneration 6. MYO1C expression is also altered in Alzheimer's disease hippocampal tissue and malocclusion development 74.

Sources cited
1
MYO1C produces three alternatively spliced isoforms with different N-terminal regions and distinct enzymatic behaviors
PMID: 28893906
2
RNF41-mediated polyubiquitination stabilizes MYO1C and promotes actin remodeling and prostate cancer metastasis
PMID: 39112516
3
MYO1C promotes wound healing through keratinocyte functions via Dock5 interaction
PMID: 39159301
4
MYO1C cooperates with KAT6B in chromatin remodeling for transcriptional regulation
PMID: 24698832
5
MYO1C serves as urinary biomarker for diabetic nephropathy and mediates podocyte injury via p38 MAPK signaling
PMID: 41569692
6
MYO1C is involved in proper rhodopsin localization in photoreceptors
PMID: 37440078
7
MYO1C expression is altered in Alzheimer's disease hippocampal tissue
PMID: 39604273
Disease Associationsⓘ20
neurodegenerative diseaseOpen Targets
0.38Weak
autosomal dominant nonsyndromic hearing lossOpen Targets
0.37Weak
cutaneous LeishmaniasisOpen Targets
0.37Weak
atrial fibrillationOpen Targets
0.17Weak
Meniere diseaseOpen Targets
0.17Weak
atrial flutterOpen Targets
0.14Weak
Miller-Dieker lissencephaly syndromeOpen Targets
0.12Weak
Miller-Dieker syndromeOpen Targets
0.12Weak
Ovarian cystOpen Targets
0.11Weak
Blackfan-Diamond anemiaOpen Targets
0.08Suggestive
neoplasmOpen Targets
0.08Suggestive
rheumatoid arthritisOpen Targets
0.07Suggestive
Hereditary persistence of fetal hemoglobin - beta-thalassemiaOpen Targets
0.06Suggestive
hereditary persistence of fetal hemoglobin-sickle cell disease syndromeOpen Targets
0.06Suggestive
inosine triphosphatase deficiencyOpen Targets
0.06Suggestive
Alpha-thalassemia - myelodysplastic syndromeOpen Targets
0.06Suggestive
alpha-thalassemia-myelodysplastic syndromeOpen Targets
0.06Suggestive
hemoglobin D diseaseOpen Targets
0.06Suggestive
alpha thalassemia-intellectual disability syndrome type 1Open Targets
0.06Suggestive
Alpha-thalassemia - intellectual disability syndrome linked to chromosome 16Open Targets
0.06Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
BAZ1BProtein interaction100%TPRNProtein interaction100%ACTG1Protein interaction98%EZRProtein interaction97%MYL6BProtein interaction97%RDXProtein interaction95%
Tissue Expression6 tissues
Lung
100%
Heart
80%
Ovary
39%
Liver
36%
Brain
5%
Bone Marrow
4%
Gene Interaction Network
Click a node to explore
MYO1CBAZ1BTPRNACTG1EZRMYL6BRDX
PROTEIN STRUCTURE
Preparing viewer…
PDB4BYF · 2.74 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.83LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.70 [0.60–0.83]
RankingsWhere MYO1C stands among ~20K protein-coding genes
  • #1,604of 20,598
    Most Researched243 · top 10%
  • #7,076of 17,882
    Most Constrained (LOEUF)0.83
Genes detectedMYO1C
Sources retrieved26 papers
Response time—
📄 Sources
26▼
1
Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5.
PMID: 39159301
Adv Sci (Weinh) · 2024
1.00
2
A noncanonical E3 ubiquitin ligase RNF41-mediated MYO1C stability promotes prostate cancer metastasis by inducing actin remodeling.
PMID: 39112516
Oncogene · 2024
0.90
3
N-terminal splicing extensions of the human
PMID: 28893906
J Biol Chem · 2017
0.80
4
Analysis of an independent tumor suppressor locus telomeric to Tp53 suggested Inpp5k and Myo1c as novel tumor suppressor gene candidates in this region.
PMID: 26170120
BMC Genet · 2015
0.76
5
MYO1C is a urinary extracellular vesicle biomarker and mediator of podocyte injury in diabetic nephropathy.
PMID: 41569692
JCI Insight · 2026
0.70